Palliative Care and COVID-19 Pandemic: Retrospective Study of Factors Associated With Infection and Death at an Oncological Palliative Care Reference Center
Open Access
- 18 January 2021
- journal article
- research article
- Published by SAGE Publications in American Journal of Hospice and Palliative Medicine®
- Vol. 38 (5) , 512-520
Abstract
Background: Advanced cancer patients are part of a group likely to be more susceptible to COVID-19. Aims: To describe the profile of advanced cancer inpatients to an exclusive Palliative Care Unit (PCU) with the diagnosis of COVID-19, and to evaluate the factors associated with death in these cases. Design: Retrospective cohort study with data from advanced cancer inpatients to an exclusive PCU, from March to July 2020, with severe acute respiratory syndrome. Diagnostic of COVID-19 and death were the dependent variables. Logistic regression analyses were performed, with the odds ratio (OR) and 95% confidence interval (CI). Results: One hundred fifty-five patients were selected. The mean age was 60.9 (±13.4) years old and the most prevalent tumor type was breast (30.3%). Eighty-three (53.5%) patients had a diagnostic confirmation of COVID-19. Having diabetes mellitus (OR: 2.2; 95% CI: 1.1-6.6) and having received chemotherapy in less than 30 days before admission (OR: 3.8; 95% CI: 1.2-12.2) were associated factors to diagnosis of COVID-19. Among those infected, 81.9% died and, patients with Karnofsky Performance Status (KPS) < 30% (OR: 14.8; 95% CI 2.7-21.6) and C-reactive protein (CRP) >21.6mg/L (OR: 9.3; 95% CI 1.1-27.8), had a greater chance of achieving this outcome. Conclusion: Advanced cancer patients who underwent chemotherapy in less than 30 days before admission and who had diabetes mellitus were more likely to develop Coronavirus 2019 disease. Among the confirmed cases, those hospitalized with worse KPS and bigger CRP were more likely to die.Keywords
This publication has 22 references indexed in Scilit:
- Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidenceInternational Journal of Antimicrobial Agents, 2020
- Clinical utility of the modified Glasgow Prognostic Score to classify cachexia in patients with advanced cancer in palliative careClinical Nutrition, 2020
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaNew England Journal of Medicine, 2020
- Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, ChinaAnnals of Oncology, 2020
- Relationship of nutritional status and inflammation with survival in patients with advanced cancer in palliative careNutrition, 2018
- The role of the systemic inflammatory response in predicting outcomes in patients with advanced inoperable cancer: Systematic review and meta -analysisCritical Reviews in Oncology/Hematology, 2017
- A systematically structured review of biomarkers of dying in cancer patients in the last months of life; An exploration of the biology of dyingPLOS ONE, 2017
- Clinical Signs of Impending Death in Cancer PatientsThe Oncologist, 2014
- Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancerInternational Journal of Colorectal Disease, 2007
- Karnofsky performance status revisited: reliability, validity, and guidelines.Journal of Clinical Oncology, 1984